Observational review links ecDNA presence to poorer survival in 2,967 children with solid tumors

This publication is an observational review analyzing genomic data from 3,630 tumor biosamples sourced from cloud-based repositories. The scope encompasses 2,967 children with childhood solid tumors, comparing the presence of circular extrachromosomal DNA (ecDNA) against chromosomal amplifications. The authors synthesize findings regarding ecDNA prevalence, composition, oncogene amplification, gene fusions, and oncogenic loci involvement as secondary outcomes alongside 5-year survival.

The key synthesized finding indicates that ecDNA was identified in 9% of cases. Furthermore, ecDNA was enriched in high-grade and clinically aggressive malignancies, including ETMR, pediatric high-grade glioma, medulloblastoma, neuroblastoma, osteosarcoma, and rhabdomyosarcoma. Oncogenes amplified on ecDNA reached significantly higher copy numbers than those found on chromosomal amplifications. The review notes that ecDNA frequently arises, is lost, or undergoes structural remodeling during disease progression and recurrence, including the acquisition or loss of oncogenes on the same circular element.

Regarding the primary outcome, ecDNA was associated with significantly poorer 5-year survival independent of tumor type, age, and sex. The authors acknowledge that the prevalence, composition, and clinical significance of ecDNA across pediatric cancers remains incompletely understood. While the study highlights candidate drivers and identifies patient populations that may benefit from emerging ecDNA-targeted therapeutic strategies, the observational nature of the data precludes definitive causal conclusions regarding treatment efficacy or specific adverse events, as these were not reported.